14.74
0.10 (0.68%)
| Penutupan Terdahulu | 14.64 |
| Buka | 14.50 |
| Jumlah Dagangan | 13,054 |
| Purata Dagangan (3B) | 81,922 |
| Modal Pasaran | 306,650,304 |
| Harga / Jualan (P/S) | 1.42 |
| Harga / Buku (P/B) | 0.660 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2026 |
| Margin Keuntungan | -41.07% |
| Margin Operasi (TTM) | -39.88% |
| EPS Cair (TTM) | -4.40 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -25.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.18% |
| Nisbah Semasa (MRQ) | 3.53 |
| Aliran Tunai Operasi (OCF TTM) | -30.88 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 9.06 M |
| Pulangan Atas Aset (ROA TTM) | -5.06% |
| Pulangan Atas Ekuiti (ROE TTM) | -17.25% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - General (US) | Menaik | Bercampur |
| Drug Manufacturers - General (Global) | Menaik | Bercampur | |
| Stok | Amarin Corporation plc | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.70 |
|
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - General |
| % Dimiliki oleh Orang Dalam | 1.88% |
| % Dimiliki oleh Institusi | 17.94% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Sarissa Capital Management Lp | 31 Dec 2025 | 1,673,395 |
| Acadian Asset Management Llc | 31 Dec 2025 | 580,442 |
| Kynam Capital Management, Lp | 31 Dec 2025 | 389,273 |
| Eversept Partners, Lp | 31 Dec 2025 | 172,188 |
| Citadel Advisors Llc | 31 Dec 2025 | 168,004 |
| Waterfront Wealth Inc. | 31 Dec 2025 | 142,540 |
| Scp Investment, Lp | 31 Dec 2025 | 100,000 |
| Lcm Capital Management Inc | 31 Dec 2025 | 42,262 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FISHMAN PETER L. | - | 14.64 | -62 | -908 |
| Jumlah Keseluruhan Kuantiti Bersih | -62 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -908 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 14.64 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| FISHMAN PETER L. | Pegawai | 01 Apr 2026 | Dibuang (-) | 62 | 14.64 | 908 |
| FISHMAN PETER L. | Pegawai | 01 Apr 2026 | Pelaksanaan pilihan | 125 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |